Literature DB >> 32299006

Latency of subthalamic nucleus deep brain stimulation-evoked cortical activity as a potential biomarker for postoperative motor side effects.

Zachary T Irwin1, Mohammad Z Awad2, Christopher L Gonzalez3, Arie Nakhmani2, J Nicole Bentley4, Thomas A Moore5, Kenneth G Smithson5, Barton L Guthrie4, Harrison C Walker3.   

Abstract

OBJECTIVE: Here, we investigate whether cortical activation predicts motor side effects of deep brain stimulation (DBS) and whether these potential biomarkers have utility under general anesthesia.
METHODS: We recorded scalp potentials elicited by DBS during surgery (n = 11), both awake and under general anesthesia, and in an independent ambulatory cohort (n = 8). Across a range of stimulus configurations, we measured the amplitude and timing of short- and long-latency response components and linked them to motor side effects.
RESULTS: Regardless of anesthesia state, in both cohorts, DBS settings with capsular side effects elicited early responses with peak latencies clustering at <1 ms. This early response was preserved under anesthesia in all participants (11/11). In contrast, the long-latency components were suppressed completely in 6/11 participants. Finally, the latency of the earliest response could predict the presence of postoperative motor side effects both awake and under general anesthesia (84.8% and 75.8% accuracy, awake and under anesthesia, respectively).
CONCLUSION: DBS elicits short-latency cortical activation, both awake and under general anesthesia, which appears to reveal interactions between the stimulus and the corticospinal tract. SIGNIFICANCE: Short-latency evoked cortical activity can potentially be used to aid both DBS lead placement and post-operative programming.
Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anesthesia; Biomarker; Deep brain stimulation; Evoked potentials

Mesh:

Substances:

Year:  2020        PMID: 32299006      PMCID: PMC7214089          DOI: 10.1016/j.clinph.2020.02.021

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  50 in total

1.  Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Jan Herzog; Urban Fietzek; Wolfgang Hamel; Andre Morsnowski; Frank Steigerwald; Bettina Schrader; Dieter Weinert; Gerd Pfister; Dieter Müller; Hubertus M Mehdorn; Günther Deuschl; Jens Volkmann
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.

Authors:  Andrea A Kühn; Andreas Kupsch; Gerd-Helge Schneider; Peter Brown
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

3.  Probabilistic analysis of activation volumes generated during deep brain stimulation.

Authors:  Christopher R Butson; Scott E Cooper; Jaimie M Henderson; Barbara Wolgamuth; Cameron C McIntyre
Journal:  Neuroimage       Date:  2010-10-23       Impact factor: 6.556

4.  A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities.

Authors:  S G Boyd; J C Rothwell; J M Cowan; P J Webb; T Morley; P Asselman; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

5.  Potentials recorded at the scalp by stimulation near the human subthalamic nucleus.

Authors:  P Ashby; G Paradiso; J A Saint-Cyr; R Chen; A E Lang; A M Lozano
Journal:  Clin Neurophysiol       Date:  2001-03       Impact factor: 3.708

6.  Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis.

Authors:  Allen L Ho; Rohaid Ali; Ian D Connolly; Jaimie M Henderson; Rohit Dhall; Sherman C Stein; Casey H Halpern
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-03-01       Impact factor: 10.154

7.  Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus.

Authors:  G Tommasi; P Krack; V Fraix; J-F Le Bas; S Chabardes; A-L Benabid; P Pollak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10-10       Impact factor: 10.154

8.  Revision Surgery of Deep Brain Stimulation Leads.

Authors:  Steven M Falowski; Roy A E Bakay
Journal:  Neuromodulation       Date:  2016-02-21

9.  Axon diameters and conduction velocities in the macaque pyramidal tract.

Authors:  L Firmin; P Field; M A Maier; A Kraskov; P A Kirkwood; K Nakajima; R N Lemon; M Glickstein
Journal:  J Neurophysiol       Date:  2014-05-28       Impact factor: 2.714

10.  Subthalamic nucleus deep brain stimulation evokes resonant neural activity.

Authors:  Nicholas C Sinclair; Hugh J McDermott; Kristian J Bulluss; James B Fallon; Thushara Perera; San San Xu; Peter Brown; Wesley Thevathasan
Journal:  Ann Neurol       Date:  2018-05-04       Impact factor: 10.422

View more
  4 in total

1.  The cortical evoked potential corresponds with deep brain stimulation efficacy in rats.

Authors:  Isaac R Cassar; Warren M Grill
Journal:  J Neurophysiol       Date:  2022-04-07       Impact factor: 2.974

2.  Image-based biophysical modeling predicts cortical potentials evoked with subthalamic deep brain stimulation.

Authors:  Bryan Howell; Faical Isbaine; Jon T Willie; Enrico Opri; Robert E Gross; Coralie De Hemptinne; Philip A Starr; Cameron C McIntyre; Svjetlana Miocinovic
Journal:  Brain Stimul       Date:  2021-03-20       Impact factor: 8.955

3.  Subthalamic deep brain stimulation of an anatomically detailed model of the human hyperdirect pathway.

Authors:  Clayton S Bingham; Cameron C McIntyre
Journal:  J Neurophysiol       Date:  2022-03-23       Impact factor: 2.974

4.  The impact of pulse timing on cortical and subthalamic nucleus deep brain stimulation evoked potentials.

Authors:  Brett A Campbell; Leonardo Favi Bocca; David Escobar Sanabria; Julio Almeida; Richard Rammo; Sean J Nagel; Andre G Machado; Kenneth B Baker
Journal:  Front Hum Neurosci       Date:  2022-09-20       Impact factor: 3.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.